Dr. Heidi Harmon, MD
Claim this profileUniversity of Iowa
Studies Arterial Tortuosity Syndrome
Studies Anti-androgen withdrawal syndrome
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
More about Heidi Harmon, MD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Heidi Harmon, MD has experience with
- Methadone
- Morphine
Breakdown of trials Heidi Harmon, MD has run
Arterial Tortuosity Syndrome
Anti-androgen withdrawal syndrome
Neonatal Abstinence Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Heidi Harmon, MD specialize in?
Heidi Harmon, MD focuses on Arterial Tortuosity Syndrome and Anti-androgen withdrawal syndrome. In particular, much of their work with Arterial Tortuosity Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Heidi Harmon, MD currently recruiting for clinical trials?
No, Heidi Harmon, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Heidi Harmon, MD has studied deeply?
Yes, Heidi Harmon, MD has studied treatments such as Methadone, Morphine.
What is the best way to schedule an appointment with Heidi Harmon, MD?
Apply for one of the trials that Heidi Harmon, MD is conducting.
What is the office address of Heidi Harmon, MD?
The office of Heidi Harmon, MD is located at: University of Iowa, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.